All posts

Follow Us

LinkedInInstagramX
Annual ResultsArchiveLast updated 16 November 20263 min read

Astonea Labs (ASTONEALAB) Q4 FY26 Revenue Jumps 51% in FY26, But Profit Slides on Costs and Cash Burn

The contract drugmaker posted its best-ever quarterly sales but saw annual profit shrink as expenses and working capital needs soared.

By Abhinav Swaroop, CFA, Chief Business Officer: Hexawealth · Created 16 November 2026

Astonea Labs' FY26 revenue surged 51% to ₹148 crore, yet net profit fell 16% to ₹4.5 crore. The March quarter saw a strong sequential rebound, but margin pressure and negative cash flow highlight underlying strains.

For a contract manufacturer like Astonea Labs, growth is a double-edged sword. Every new order boosts revenue but also ties up cash in raw materials and receivables before a rupee of profit is earned. The company’s FY26 numbers capture that tension perfectly: a 51% surge in sales met a 16% drop in annual profit.

The final quarter provided a sharp sequential rebound. Revenue rose 23% from the September quarter to ₹81 crore, while profit tripled to ₹3 crore. This lifted the quarterly net margin to 3.7%, a recovery from 1.5% three months earlier.

Revenue & profit

Revenue (₹ Cr)

Profit (₹ Cr)

Revenue & profitQ2 FY25 (Sep 2024) 47.0, Q2 FY26 (Sep 2025) 66.0, Q4 FY26 (Mar 2026) 81.0. Q2 FY25 (Sep 2024) 2.0, Q2 FY26 (Sep 2025) 1.0, Q4 FY26 (Mar 2026) 3.0050100150200Q2 FY25 (Sep 2024)Q2 FY26 (Sep 2025)Q4 FY26 (Mar 2026)
  • Revenue (₹ Cr), Q2 FY25 (Sep 2024): 47.0
  • Revenue (₹ Cr), Q2 FY26 (Sep 2025): 66.0
  • Revenue (₹ Cr), Q4 FY26 (Mar 2026): 81.0
  • Profit (₹ Cr), Q2 FY25 (Sep 2024): 2.0
  • Profit (₹ Cr), Q2 FY26 (Sep 2025): 1.0
  • Profit (₹ Cr), Q4 FY26 (Mar 2026): 3.0

Revenue (₹ Cr)

Revenue (₹ Cr)Q2 FY25 (Sep 2024) 47.0, Q2 FY26 (Sep 2025) 66.0, Q4 FY26 (Mar 2026) 81.0050100150200Q2 FY25 (Sep 2024)Q2 FY26 (Sep 2025)Q4 FY26 (Mar 2026)
  • Revenue (₹ Cr), Q2 FY25 (Sep 2024): 47.0
  • Revenue (₹ Cr), Q2 FY26 (Sep 2025): 66.0
  • Revenue (₹ Cr), Q4 FY26 (Mar 2026): 81.0

Profit (₹ Cr)

Profit (₹ Cr)Q2 FY25 (Sep 2024) 2.0, Q2 FY26 (Sep 2025) 1.0, Q4 FY26 (Mar 2026) 3.001234Q2 FY25 (Sep 2024)Q2 FY26 (Sep 2025)Q4 FY26 (Mar 2026)
  • Profit (₹ Cr), Q2 FY25 (Sep 2024): 2.0
  • Profit (₹ Cr), Q2 FY26 (Sep 2025): 1.0
  • Profit (₹ Cr), Q4 FY26 (Mar 2026): 3.0

Net Profit Margin

Net Profit MarginQ2 FY25 (Sep 2024) 4.3%, Q2 FY26 (Sep 2025) 1.5%, Q4 FY26 (Mar 2026) 3.7%0%2%4%6%8%Q2 '25Q2 '26Q4 '26
  • Net Profit Margin, Q2 FY25 (Sep 2024): 4.3%
  • Net Profit Margin, Q2 FY26 (Sep 2025): 1.5%
  • Net Profit Margin, Q4 FY26 (Mar 2026): 3.7%
MetricCurrentQ4 FY26 (Mar 2026)PreviousQ2 FY26 (Sep 2025)
Revenue (₹ Cr)
81.0
66.0
Profit (₹ Cr)
3.0
1.0
Net Profit Margin
3.7%
1.5%

Why Margins Crumbled on Higher Sales

The full-year story is one of costs outpacing growth. Operating profit margin fell 640 basis points to 9.5%, as total expenses ballooned by 63%. According to reports from Stockwatch.live and newboard.in, this was driven by strategic investments in distribution and branding, alongside the inherent volatility of contract manufacturing margins.

The business model explains the pressure. Astonea buys materials, makes the product, and charges the customer per order. Revenue includes the full material cost, so profitability hinges on order mix and pricing power, which the company admits is limited in a competitive market.

The Cash Flow Conundrum

The most striking figure is a ₹13.7 crore operating cash outflow for FY26, a dramatic reversal from a ₹9.3 crore inflow the year before. This occurred despite the company reporting an operating profit.

Live Chart

· ASTONEALAB

(BSE)

ISIN: INE0TG901011

Reports from Multibagg.ai and newboard.in point to a ₹24 crore increase in working capital, mainly from higher inventory and receivables. As sales grow, more cash gets locked up funding that growth before customers pay. This has pushed gross borrowings to ₹57 crore as of September 2026, up from ₹43 crore in March.

A Guidance-Driven Rebound

Management has framed FY26 as an investment year, with a sharp recovery already underway. The company reported what it called its "best half ever" for H1 FY27, with revenue up 45% and margins expanding.

Guiding for FY27 revenue of at least ₹215 crore and an EBITDA margin of 13-15%, as reported by MCapital.in, the plan relies on growing its own over-the-counter brands and exports. Success hinges on converting this guidance into sustained profits and, critically, converting those profits into cash.

Key Points

  • Annual revenue grew 51% to ₹147.6 crore, but net profit fell 16% to ₹4.5 crore due to a sharp contraction in operating margins.
  • The company consumed ₹13.7 crore in operating cash during FY26 as working capital needs surged with sales growth.
  • Management forecasts a strong rebound, guiding for FY27 revenue above ₹215 crore with significantly improved profitability.
  • Execution risks remain high, centered on margin stability and the ability to fund growth without further straining the balance sheet.

Hexa Perspective

The quarter ends a year of aggressive top-line expansion that came at a cost to profitability and cash generation. The guidance for FY27 is exceptionally bullish, projecting nearly 100% profit growth on the back of higher-margin own brands.

The market is pricing in this promised turnaround, with the stock trading at a significant premium to the sector. The next few quarters will test whether Astonea can break the cycle of revenue growth funded by debt and working capital, delivering the cash flow needed to sustain its ambitious targets.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Astonea Labs (ASTONEALAB) Q4 FY26 results, revenue and profits.

Frequently asked questions

What were Astonea Labs' Q4 FY26 results?
Astonea Labs reported Q4 FY26 (March 2026 quarter) revenue of ₹81 crore and a net profit of ₹3 crore. This represented a 23% sequential revenue growth from the previous quarter and a tripling of quarterly profit, lifting the net profit margin to 3.7%.
What was Astonea Labs' FY26 net profit?
For the full financial year ended March 2026, Astonea Labs reported a consolidated net profit of ₹4.52 crore. This was a 15.6% decline from the ₹5.35 crore profit reported in FY25, despite a 51.3% jump in annual revenue to ₹147.58 crore.
Why did Astonea Labs' profit fall in FY26 despite higher sales?
Astonea Labs' FY26 profit fell because total expenses grew faster than revenue, rising 63% year-on-year. This compressed the operating profit margin by 640 basis points to 9.5%. Reports suggest the squeeze was due to strategic investments and the variable nature of contract manufacturing margins.
Why was Astonea Labs' operating cash flow negative in FY26?
Astonea Labs had a ₹13.65 crore operating cash outflow in FY26 because a ₹24 crore increase in working capital, mainly from inventory and receivables, consumed cash. This outflow occurred despite the company generating an operating profit, highlighting the cash-intensive nature of its growth.
What is Astonea Labs' debt position?
As of March 31, 2026, Astonea Labs had total borrowings of ₹43 crore. Subsequent reports indicate gross borrowings rose to ₹57.15 crore by September 2026 to fund working capital needs. The company's debt-to-equity ratio was 0.75 at the end of FY26.
What guidance did Astonea Labs give for FY27?
Astonea Labs management, as reported by outlets like MCapital.in, guided for FY27 revenue of ₹215 crore or more, with an EBITDA margin target of 13-15% and a net profit margin of 5-6%. This implies significant growth and margin expansion from the FY26 base.
What is driving Astonea Labs' revenue growth?
Astonea Labs' revenue growth is driven by its contract manufacturing business and a growing contribution from its own over-the-counter (OTC) pharmaceutical brands. The company's H1 FY27 performance showed a 45% revenue jump, which management attributes to this brand mix shift.
What is the P/E ratio of Astonea Labs?
Based on FY26 earnings, Astonea Labs trades at a price-to-earnings (P/E) ratio of 81.4. This is a significant premium to the industry P/E of 40.6, reflecting market expectations for the high growth projected in management's guidance.
Astonea Labs FY26 revenue from operations
Astonea Labs' revenue from operations for FY26 (year ended March 2026) was ₹147.58 crore. This marked a strong 51.3% growth from the ₹97.52 crore revenue reported in the prior financial year.
Astonea Labs Q4 FY26 results March 2026
Astonea Labs' Q4 FY26 results for the March 2026 quarter showed revenue of ₹81 crore and net profit of ₹3 crore. The quarterly net profit margin was 3.7%, a sequential improvement from 1.5% in the September 2025 quarter.